Search

Commonalities and Differences in Myeloid Malignancies: Insights from the EHA-SWG Scientific Meeting on MDS, MPN, and AML

Dec 08 2023

November 2-4 - Budapest, Hungary

Meeting Chairs:

Konstanze Döhner, University Hospital Ulm, Germany
Claire Harrison, Guy's and St.

Daratumumab Shows Remarkable Benefit in Relapsed or Refractory Multiple Myeloma in the POLLUX Study

Jun 10 2016 Posted in Press releases

Daratumumab is a fully human monoclonal antibody that binds to a novel target on myeloma cells.

Press release: Work of 2013 Nobel Prize in Physiology or Medicine winners to be presented at the 18th Congress of the European Hematology Association in Stockholm, June 13-16, 2013

Jun 10 2013 Posted in Press releases

With the Scientific Working Group for Stem Cells, the 18th Congress of EHA took the opportunity to acknowledge the work of the 2013 winner of the Nobel Prize for Medicine or Physiology, Drs John B.

International Survey of T2* Cardiovascular Magnetic Resonance in Thalassemia

Jun 15 2012 Posted in Press releases

Thalassemia major (TM) is a substantial health issue, with over 25,000 new transfusion- dependent children identified each year around the world.

Sickle Cell Disease: From Research to Clinical Management

Elevate your expertise and impact patient care by joining the EHA's pilot preceptorship on Sickle Cell Disease, designed for early-career hematology specialists, clinicians, lab technicians, and pathologists.

EHA-AHA-GBMA Mini Hematology Tutorial

For the first time EHA is collaborating simultaneously with the Armenian Hematology Association (AHA) and Georgian Association For Blood and Bone Marrow Transplantation (GBMTA) in a virtual Mini Hematology Tutorial.